Zynerba Pharmaceuticals, Inc. (ZYNE) Social Stream



Zynerba Pharmaceuticals, Inc. (ZYNE): $2.37

-0.01 (-0.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Zynerba Pharmaceuticals Inc (ZYNE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Zynerba Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-06 4 $9 $3.5 $7.15 $2.38 200.42%
2022-01-06 5 $9 $3.5 $7.15 $2.38 200.42%
2021-11-18 5 $9 $4.5 $7.35 $2.38 208.82%

The Trend in the Analyst Price Target


ZYNE's average price target has moved down $0.48 over the prior 35 weeks.

Over the past 47 weeks, ZYNE's average upside potential has been 74.82%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-03-08 2 9 4.5 7.25 4.14 75.12%
2021-05-21 4 9 4.5 7.63 4.84 57.64%
2021-05-15 4 9 4.5 7.63 4.46 71.08%
2021-04-10 4 9 4.5 7.29 4.28 70.33%
2021-09-11 4 9 4.5 7.63 4.47 70.69%

ZYNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ZYNE as an investment opportunity.

  • In the context of all US stocks, Zynerba Pharmaceuticals Inc's average analyst price target is higher than 17.86% of them.
  • In the context of all US stocks, Zynerba Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 264.83% of them.
  • Zynerba Pharmaceuticals Inc's number of analysts covering the stock is greater than 258.26% of stocks in the micro market cap category.
  • In the context of stocks in the micro market cap category, Zynerba Pharmaceuticals Inc's variance in analysts' estimates is lower than -152.51% of them.

Stocks similar to Zynerba Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZSAN, XCUR, and VTVT.

What is the outlook for ZYNE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8507 seconds.